News

New York Post4d
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.
Yahoo Finance5d
Novo Nordisk, Charter & Cox, Take Two: Trending Tickers
Novo Nordisk's (NVO) CEO Lars Fruergaard Jørgensen is set to step down. Charter (CHTR) and Cox Communications announce a merger in a $34.5 billion deal. Take Two (TTWO) forecasts weak 2026 ...
Wall Street Journal4d
Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges
Ozempic maker Novo Nordisk NOVO.B-1.81%decrease; red down pointing triangle pushed out its chief executive after losing ground in the anti-obesity drug market, which has caused a steep ...
Novo Nordisk hopes to see US Wegovy sales recover soon
Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...
The Motley Fool4d
Why Novo Nordisk Stock Just Slipped
Novo Nordisk CEO Lars Fruergaard Jørgensen will resign from the company after a short transition period. His replacement has not yet been found. Novo Nordisk stock is down 50% in 12 months ...
The Financial Times5d
Novo Nordisk ousts boss as Ozempic maker battles slump
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Novo Nordisk has ousted chief executive Lars Fruergaard Jørgensen as the maker of pioneering obesity drug ...
TwinCities.com4d
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S, maker of blockbuster weight loss drug Wegovy, said Friday its CEO was stepping down by “mutual agreement” with the ...